Latest News and Press Releases

Company announcement – No. 6 / 2023 Zealand Pharma Provides Update on Silicon Valley Bank Closure Update to company announcement No.5 following joint statement by U.S. Treasury, Federal Reserve,...

Company announcement – No. 5 / 2023 Zealand Pharma Provides Statement on Silicon Valley Bank Closure Copenhagen, Denmark March 12, 2023 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no....

Company announcement – No. 4 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...

Company announcement – No. 3 / 2023 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, March 9, 2023 – Zealand Pharma A/S (“Zealand”)...

Correction: Company Announcement – No. 2 / 2023 Zealand convenes its Annual General Meeting 2023 Notice to convene the Annual General Meeting of Zealand Pharma A/S (CVR no. 20 04 50 78) (the...

Company announcement – No. 1 / 2023 Correction: Zealand Pharma Announces Full Year Results for 2022 Successful organizational transformation and progress across the R&D...

Company Announcement – No. 2 / 2023 Zealand convenes its Annual General Meeting 2023 Notice to convene the Annual General Meeting of Zealand Pharma A/S (CVR no. 20 04 50 78) (the "Company"). The Board...

Company announcement – No. 1 / 2023 Zealand Pharma Announces Full Year Results for 2022 Successful organizational transformation and progress across the R&D pipelineTwo regulatory...

Press release – No. 1 / 2023 Zealand Pharma to Host Conference Call on March 2, 2023 at 2 pm CET (8 am ET) to Present Full Year Results for 2022 Copenhagen, Denmark February...

Company announcement – No. 58 / 2022 Total number of shares and voting rights in Zealand Pharma at December 30, 2022 Copenhagen, Denmark and Boston, MA, U.S. December 30, 2022 – Zealand...